These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6522325)

  • 1. [Use of drugs in children with renal failure].
    Prandota J; Sarul H
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1731-4. PubMed ID: 6522325
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacokinetics in renal insufficiency].
    Arancibia A; Ruiz I
    Rev Med Chil; 1984 Mar; 112(3):267-75. PubMed ID: 6473969
    [No Abstract]   [Full Text] [Related]  

  • 3. [Letter: Kinetics of elimination and dosage of digoxin in patients with kidney failure].
    Risler T
    Dtsch Med Wochenschr; 1974 Oct; 99(42):2130-1. PubMed ID: 4426236
    [No Abstract]   [Full Text] [Related]  

  • 4. [Elimination kinetics and dosage of digoxin in patients in renal failure (author's transl)].
    Ohnhaus EE; Spring P; Dettli L
    Dtsch Med Wochenschr; 1974 Sep; 99(37):1797-803. PubMed ID: 4457307
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal clearance of digoxin in young infants.
    Gorodischer R; Jusko WJ; Yaffe SJ
    Res Commun Chem Pathol Pharmacol; 1977 Feb; 16(2):363-74. PubMed ID: 847290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between plasma ampicillin clearance and endogenous creatinine clearance. III].
    Sieniawska M; Wróblewska-Kałuzewska M; Wierzbowska-Lange B; Wierzba K
    Pediatr Pol; 1980 Jun; 55(6):683-9. PubMed ID: 7413316
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antibiotic therapy in renal failure (author's transl)].
    Humair L
    Munch Med Wochenschr; 1973 Sep; 115(39):1657-60. PubMed ID: 4801047
    [No Abstract]   [Full Text] [Related]  

  • 8. [Relationship between plasma cephalothin clearance and endogenous creatinine clearance. V].
    Sieniawska M; Wróblewska-Kałuzewska M; Białasik D; Karczeńska J; Wierzba K
    Pediatr Pol; 1980 Jun; 55(6):699-705. PubMed ID: 7413318
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal clearance of digoxin in premature neonates.
    Ng PK; Cote J; Schiff D; Collins-Nakai RL
    Res Commun Chem Pathol Pharmacol; 1981 Nov; 34(2):207-16. PubMed ID: 7335951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of drugs on neonates, infants and school children. 2. Pharmacokinetics and pharmacodynamics].
    Reinhardt D; Richter O
    Fortschr Med; 1982 Feb; 100(7):271-6. PubMed ID: 7076093
    [No Abstract]   [Full Text] [Related]  

  • 11. Decreased volume of distribution of digoxin in a patient with renal failure.
    Szefler SJ; Jusko WJ
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):1095-8. PubMed ID: 4760884
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacokinetic approaches to the use of digoxin in heart failure in patients with chronic end-stage renal failure].
    Kholodov LE; Glezer MG; Grigor'eva EA; Ksenzenko BL
    Kardiologiia; 1983 Jul; 23(7):103-5. PubMed ID: 6620803
    [No Abstract]   [Full Text] [Related]  

  • 13. Digoxin pharmacokinetics: role of renal failure in dosage regimen design.
    Koup JR; Jusko WJ; Elwood CM; Kohli RK
    Clin Pharmacol Ther; 1975 Jul; 18(1):9-21. PubMed ID: 1149366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels and elimination of thiamphenicol in patients with impaired liver function and with renal failure on dialysis.
    Oldershausen HF; Menz HP; Hartmann I; Bezler HJ; Ilg R; Burck GC
    Postgrad Med J; 1974 Oct; 50 Suppl 5():44-6. PubMed ID: 4470818
    [No Abstract]   [Full Text] [Related]  

  • 15. Absolute bioavailability of digoxin in chronic renal failure.
    Ohnhaus EE; Vozeh S; Nüesch E
    Clin Nephrol; 1979 Jun; 11(6):302-6. PubMed ID: 477047
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetic aspects of digoxin in patients with terminal renal failure. IV. Clinical implications of own observations with a recent review of literature.
    van der Vijgh WJ; Oe PL
    Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):540-6. PubMed ID: 730421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clearance of digoxin in persons with healthy kidneys and in patients with reduced renal function].
    Risler T; Grabensee B; Hausamen TU; Schröder E; Grosse-Brockhoff F
    Verh Dtsch Ges Kreislaufforsch; 1974; 40():306-8. PubMed ID: 4450674
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serum levels of cephalothin, ampicillin and cloxacillin in children with and without renal failure].
    Sieniawaska M; Wróblewska-Kałuzewska M; Wierzbowska-Lange B; Korniszewska J; Kaźmirowska Z; Suska A; Janecki J
    Pediatr Pol; 1974 Feb; 49(2):133-41. PubMed ID: 4549872
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in trimethoprim levels and its pharmacokinetic parameters in children with chronic renal failure treated with biseptol. I].
    Sieniawska M; Białasik D; Wróblewska-Kałuzewska M; Korniszewska J; Wierzbowska-Lange B; Karczeńska J; Wierzba K
    Pediatr Pol; 1984 Mar; 59(3):177-87. PubMed ID: 6610853
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics of buflomedil after intravenous administration in patients with chronic renal failure.
    Rey E; d'Athis P; Richard MO; Fillastre JP; Olive G
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):648-52. PubMed ID: 6526539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.